Jodie A. Field
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Teva Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Cervical Cancer and HPV Research, Vector-borne infectious diseases, Reproductive tract infections research, Toxin Mechanisms and Immunotoxins, Urinary Tract Infections Management
Most-Cited Works
- → Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis(1998)520 cited
- → Association of antibiotic treatment-resistant lyme arthritis with T cell responses to dominant epitopes of outer surface protein A ofBorrelia burgdorferi(1999)108 cited
- → Establishing Acceptance Criteria for Cell-Mediated-Immunity Assays Using Frozen Peripheral Blood Mononuclear Cells Stored under Optimal and Suboptimal Conditions(2007)94 cited
- → Different Classes of Proteoglycans Contribute to the Attachment of Borrelia burgdorferi to Cultured Endothelial and Brain Cells(1998)88 cited
- → Cellular and Humoral Immune Responses toBorrelia burgdorferiAntigens in Patients with Culture-Positive Early Lyme Disease(2001)64 cited
- → Roles of IL-1 and TNF-alpha in endotoxin-induced activation of nitric oxide synthase in cultured rat brain cells(1996)59 cited
- → Memory T-Cell Response to Rotavirus Detected with a Gamma Interferon Enzyme-Linked Immunospot Assay(2005)37 cited
- → A real-time quantitative polymerase chain reaction assay for the detection of Chlamydia in the mouse genital tract model(2008)19 cited
- → A novel automated method for enumeration of Chlamydia trachomatis inclusion forming units(2007)13 cited
- → Evaluating Potential Vaccine Antigens in both the <i>Chlamydia trachomatis</i> and <i>Chlamydia muridarum</i> Intravaginal Mouse Challenge Models(2019)4 cited